Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates — Negative
BVS Zacks Investment Research — August 06, 2025Bioventus (BVS) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago.

The New York Times Company (NYT) Q2 2025 Earnings Call Transcript — Neutral
NYT Seeking Alpha — August 06, 2025The New York Times Company (NYSE:NYT ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anthony Joseph DiClemente - Senior Vice President of Investor Relations Meredith A. Kopit Levien - CEO, President & Director William Bardeen - Executive VP & Chief Financial Officer Conference Call Participants Benjamin Soff - Deutsche Bank AG, Research Division David Karnovsky - JPMorgan Chase & Co, Research Division Douglas Middleton Arthur - Huber Research Partners, LLC Jason Boisvert Bazinet - Citigroup Inc. Exchange Research Kutgun Maral - Evercore ISI Institutional Equities, Research Division Thomas L.

Stock Market Live August 6: Mostly Positive Earnings Reports Push S&P 500 (VOO) Higher Wednesday — Positive
VOO 24/7 Wall Street — August 06, 2025On a quiet day for macroeconomic news, earnings dominate market action Wednesday morning.

Mosaic's Q2 Earnings and Revenues Miss, Phosphate Volumes Fall — Negative
MOS Zacks Investment Research — August 06, 2025MOS posts Q2 earnings miss as lower phosphate volumes weigh on results despite higher margins.

Despite Fast-paced Momentum, Kennametal (KMT) Is Still a Bargain Stock — Positive
KMT Zacks Investment Research — August 06, 2025Kennametal (KMT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Here's Why Momentum in Build-A-Bear (BBW) Should Keep going — Positive
BBW Zacks Investment Research — August 06, 2025Build-A-Bear (BBW) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Why Fast-paced Mover Pitney Bowes (PBI) Is a Great Choice for Value Investors — Positive
PBI Zacks Investment Research — August 06, 2025Pitney Bowes (PBI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Why Investors Need to Take Advantage of These 2 Utilities Stocks Now — Positive
SRE XEL Zacks Investment Research — August 06, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Why Fast-paced Mover Quad/Graphics (QUAD) Is a Great Choice for Value Investors — Positive
QUAD Zacks Investment Research — August 06, 2025Quad/Graphics (QUAD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Beats Revenue Estimates — Neutral
ACB Zacks Investment Research — August 06, 2025Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.18. This compares to a loss of $0.11 per share a year ago.

Inspired Entertainment (INSE) Reports Q2 Loss, Beats Revenue Estimates — Neutral
INSE Zacks Investment Research — August 06, 2025Inspired Entertainment (INSE) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.07 per share a year ago.

White House says Apple to announce $100B US investment commitment for manufacturing — Positive
AAPL Fox Business — August 06, 2025The White House said Apple will announce an additional $100 billion investment in American facilities, to support jobs and domestic manufacturing under Trump's economic agenda.

SILVERSEA UNVEILS NEW IMMERSIVE OUTDOOR EXPERIENCES AT THE CORMORANT AT 55 SOUTH AHEAD OF ITS JANUARY 2026 OPENING — Neutral
RCL PRNewsWire — August 06, 2025New land offerings in Puerto Williams, Chile, will connect guests to Tierra del Fuego's wildlife, landscapes, and culture, enhancing the journey for guests traveling on Silversea's innovative Antarctica Fly Cruise sailings Watch a new video on The Cormorant at 55 South: Stories by Silversea: A Legacy in the Making: Part 2 MIAMI , Aug. 6, 2025 /PRNewswire/ -- Silversea, the leading experiential luxury and expedition travel brand, has unveiled highlights of the land offerings available at its highly-anticipated hotel, The Cormorant at 55 South in Puerto Williams, Chile – scheduled to open in January 2026. Nestled in the heart of …

Will JPMorgan-Coinbase Tie-Up Bring Crypto Closer to Mainstream? — Positive
COIN JPM Zacks Investment Research — August 06, 2025JPM partners with COIN to enable direct crypto access, stablecoin rewards and tokenized banking. This marks a major step toward mainstream adoption of crypto.

Arista Beats Q2 Earnings Estimates on Healthy Top-Line Growth — Positive
ANET Zacks Investment Research — August 06, 2025ANET tops Q2 estimates as strong demand and innovative products drive record revenues and profit growth.

eHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates — Negative
EHTH Zacks Investment Research — August 06, 2025eHealth (EHTH) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to a loss of $1.09 per share a year ago.

Jones Lang LaSalle (JLL) Beats Q2 Earnings and Revenue Estimates — Positive
JLL Zacks Investment Research — August 06, 2025Jones Lang LaSalle (JLL) came out with quarterly earnings of $3.3 per share, beating the Zacks Consensus Estimate of $3.2 per share. This compares to earnings of $2.55 per share a year ago.

Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates — Positive
LXRX Zacks Investment Research — August 06, 2025Lexicon Pharmaceuticals (LXRX) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.17 per share a year ago.

Griffon (GFF) came out with quarterly earnings of $1.5 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.24 per share a year ago.

Our $20,000 Portfolio Yields 9.3% and Has Crushed the S&P 500 Over 5 Years — Positive
CSWC FDUS MAIN TSLX 24/7 Wall Street — August 06, 2025Investors love dividend stocks, especially those with ultra-high yields, because they provide a substantial income stream and offer significant total return potential.
